Neuroleptic Malignant Syndrome (nms) - Toxicology

Relevant Publications

Bilingual side effect: a case of foreign language syndrome following chlorpromazine-induced neuroleptic malignant syndrome.

Issue Release: 2025

Bromocriptine for Residual Catatonia Following Neuroleptic Malignant Syndrome: Illustrative Case Report and Systematic Review.

Issue Release: 2025

Successful Treatment of Both Refractory Neuroleptic Malignant Syndrome and Subsequent Catatonia With Electroconvulsive Therapy in a Patient With Suspected Kufs Disease.

Issue Release: 2024

Dual Toxidrome of Anti-cholinergic Storm and Neuroleptic Malignant Syndrome: A Therapeutic Challenge Overcome by Intrathecal Neostigmine.

Issue Release: 2024

Transient Fever Response After ECT in a Patient with Catatonic Schizophrenia: A Case Report.

Issue Release: 2024

Neuroleptic malignant syndrome after overdose of haloperidol - A case report.

Issue Release: 2024

A rare case of prochlorperazine-induced neuroleptic malignant syndrome.

Issue Release: 2024

First generation antipsychotic-associated serious adverse events in women: a retrospective analysis of a pharmacovigilance database.

Issue Release: 2024

Integrating Physiotherapy in Neuroleptic Malignant Syndrome Management: A Case Report.

Issue Release: 2024

Atypical Neuroleptic Malignant Syndrome With Type 2 Respiratory Failure Treated With Non-invasive Ventilation.

Issue Release: 2024

Parkinsonism-Hyperpyrexia Syndrome in a patient undergoing upper gastrointestinal surgery: A case report.

Issue Release: 2024

Neuroleptic Malignant Syndrome: An Intensive Care Unit Case of Exceptionally High Creatinine Kinase and Myoglobin Levels.

Issue Release: 2024

Haloperidol-Induced Neuroleptic Malignant Syndrome: A Case Report.

Issue Release: 2024

The Atypical Face of Neuroleptic Malignant Syndrome: A Case Report of Ileus and Absent Rigidity.

Issue Release: 2024

Long prodromal symptoms of neuroleptic malignant syndrome in patient with intellectual developmental disorder-A case report.

Issue Release: 2024

Neuroleptic Malignant Syndrome with Low-dose Quetiapine After Venlafaxine Withdrawal: A Case Report.

Issue Release: 2024

Neuroleptic malignant syndrome in Huntington disease.

Issue Release: 2024

Neuroleptic Malignant Syndrome in a 10-Month-Old Ex-Preterm Infant with Delirium.

Issue Release: 2024

A real-world pharmacovigilance study of neuroleptic malignant syndrome based on FDA adverse event reporting system.

Issue Release: 2024

Neuroleptic Malignant Syndrome Concurrent with COVID-19 Infection: A Case Report.

Issue Release: 2024

How Does VR Enhance Toxicological Research?

How Do Corporations Influence Toxicology?

How is Risk of Toxicity Assessed?

What is Reversibility in Toxicology?

What are Target Specific Proteins?

Why are Target Proteins Important?

How Can Consumers Assess the Safety of Functional Foods?

How Do Stable Isotopes Enhance Toxicological Research?

Why is Toxicology Important in the Workplace?

What Education and Training are Required?

Partnered Content Networks

Relevant Topics